FDA Pilot Program Eases Rules for Nicotine Pouch Makers 
NASA and SpaceX Target Crew-11 Undocking From ISS Amid Medical Concern 
Neuralink Plans High-Volume Brain Implant Production and Fully Automated Surgery by 2026 
Tokyo Inflation Rises in August as BOJ Rate Hike Bets Grow 
Bank of Korea Raises Rates to 3% as Inflation Stays Sticky 
SpaceX’s Starship Completes 11th Test Flight, Paving Way for Moon and Mars Missions 
US Dollar Hits Two-Week High After Hawkish Fed Speech 
Asian Currencies Mixed as Dollar Holds Firm Ahead of Jackson Hole 
SpaceX Delays Starship V3 Launch Ahead of Potential Record IPO 
Wall Street Slips as Warsh’s Hawkish Fed Speech Rattles Markets 
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment 
Fed Chair Warsh Faces Key Jackson Hole Test 
NASA Artemis II: First Crewed Moon Mission Since Apollo Takes Four Astronauts on 10-Day Lunar Journey 
Asian Currencies Steady Ahead of Warsh Speech 
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage 
Add as a preferred source on Google
Tofurky, a processor of plant-analog proteins, will collaborate with Triton Algae Innovations to develop products incorporating protein from “essential red” algae.
Jaime Athos, CEO of Tofurky, said that the opportunity for the companies to combine their knowledge and understanding of the plant-based market with the nutrition and natural supply-chain technology created by Triton’s algae is unique and timely.
The process involves the selection and cultivation of algae strains that are rich in protein, omega-3 fatty acids, and other beneficial nutrients.
The products would be rolled out in the first quarter of next year, although the company's announcement did not furnish any descriptions or other specifics.
Athos noted that while they can’t share just yet what the products are, it would resonate with their core audience and be attractive to the rapidly growing flexitarian segment who are increasingly drawn to plant-based foods.
